Molecular analysis of thyroid tumors (Q37860130)

24 August 2017

1 reference

title

Molecular analysis of thyroid tumors (English)

1 reference

24 August 2017

Yuri E Nikiforov

1

1 reference

24 August 2017

publication date

1 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

24 Suppl 2

1 reference

24 August 2017

page(s)

S34-43

1 reference

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

RET/PTC rearrangement in thyroid tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

RET oncogene activation in papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

RET/PTC activation in hyalinizing trabecular tumors of the thyroid

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Hyalinizing Trabecular Tumor of the Thyroid: A Variant of Papillary Carcinoma Proved By Molecular Genetics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Ras oncogene mutations in benign and malignant thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Prevalence of Ras mutations in thyroid neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Ras mutations are rare in solitary cold and toxic thyroid nodules

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Genetic and biological subgroups of low-stage follicular thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Changing trends in thyroid practice: understanding nodular thyroid disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Management of a solitary thyroid nodule

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Clinical implications of pre-operative rapid BRAF analysis for papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

PCR amplification and analysis of ras oncogenes from thyroid cytologic smears

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

The prevalence and prognostic value of BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Management of low-risk differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.167

7 January 2021

10.1038/MODPATHOL.2010.167

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1042692394

0 references

1 reference